ArticleInternational journal of molecular sciences2023

Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy.

Anastasia Ryapolova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.